Down the drain: Reconsidering routine urine drug testing during the COVID-19 pandemic.
Journal
Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
06
06
2020
revised:
30
07
2020
accepted:
29
09
2020
entrez:
10
12
2020
pubmed:
11
12
2020
medline:
22
12
2020
Statut:
ppublish
Résumé
The COVID-19 pandemic and the move to telemedicine for office-based opioid treatment have made the practice of routine urine drug tests (UDT) obsolete. In this commentary we discuss how COVID-19 has demonstrated the limited usefulness and possible harms of routine UDT. We propose that practitioners should stop using routine UDT and instead use targeted UDT, paired with clinical reasoning, as part of a patient-centered approach to care.
Identifiants
pubmed: 33298297
pii: S0740-5472(20)30412-8
doi: 10.1016/j.jsat.2020.108155
pmc: PMC7534596
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
108155Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Références
Int J Drug Policy. 2020 Apr 17;79:102722
pubmed: 32311513
Am J Drug Alcohol Abuse. 2019;45(4):333-340
pubmed: 31084515
JAMA. 2019 Jul 8;:
pubmed: 31282953
Drug Alcohol Depend. 2020 May 1;210:107958
pubmed: 32203863
Drug Alcohol Depend. 2019 Apr 1;197:78-82
pubmed: 30784952
J Addict Med. 2017 May/Jun;11(3):163-173
pubmed: 28557958
Ann Intern Med. 2018 Nov 6;169(9):628-635
pubmed: 30357262
J Subst Abuse Treat. 2015 May;52:48-57
pubmed: 25601365
J Subst Abuse Treat. 2009 Dec;37(4):426-30
pubmed: 19553061